Technical Analysis for AKRO - Akero Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | -4.26% | |
MACD Bearish Signal Line Cross | Bearish | -4.26% | |
Down 3 Days in a Row | Weakness | -4.26% | |
Down 4 Days in a Row | Weakness | -4.26% | |
Down 5 Days in a Row | Weakness | -4.26% | |
Earnings Movers | Other | -8.43% | |
Down 3 Days in a Row | Weakness | -8.43% | |
Down 4 Days in a Row | Weakness | -8.43% | |
Earnings Movers | Other | -10.26% | |
Outside Day | Range Expansion | -10.26% |
Alert | Time |
---|---|
Down 3% | about 2 hours ago |
Possible NR7 | about 3 hours ago |
60 Minute Opening Range Breakdown | about 4 hours ago |
Down 2 % | about 7 hours ago |
Down 1% | about 7 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Akero Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of transformative treatments for patients with serious metabolic diseases with high unmet medical need. The company's lead program AKR-001 is being evaluated in a Phase 2a clinical trial for the treatment of non-alcoholic steatohepatitis (NASH).
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Metabolic Disease Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Alcohol Clinical Trial Metabolic Disease Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 37.0 |
52 Week Low | 13.86 |
Average Volume | 539,876 |
200-Day Moving Average | 25.04 |
50-Day Moving Average | 29.36 |
20-Day Moving Average | 31.52 |
10-Day Moving Average | 32.89 |
Average True Range | 1.71 |
RSI (14) | 48.98 |
ADX | 31.22 |
+DI | 24.40 |
-DI | 20.67 |
Chandelier Exit (Long, 3 ATRs) | 30.75 |
Chandelier Exit (Short, 3 ATRs) | 33.52 |
Upper Bollinger Bands | 35.25 |
Lower Bollinger Band | 27.79 |
Percent B (%b) | 0.43 |
BandWidth | 23.65 |
MACD Line | 1.07 |
MACD Signal Line | 1.16 |
MACD Histogram | -0.087 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 33.72 | ||||
Resistance 3 (R3) | 34.02 | 33.40 | 33.26 | ||
Resistance 2 (R2) | 33.40 | 32.70 | 33.25 | 33.11 | |
Resistance 1 (R1) | 32.19 | 32.27 | 31.88 | 31.89 | 32.96 |
Pivot Point | 31.57 | 31.57 | 31.41 | 31.42 | 31.57 |
Support 1 (S1) | 30.35 | 30.87 | 30.04 | 30.05 | 28.98 |
Support 2 (S2) | 29.73 | 30.43 | 29.58 | 28.83 | |
Support 3 (S3) | 28.52 | 29.73 | 28.68 | ||
Support 4 (S4) | 28.22 |